FDA product code GZF: Stimulator, Peripheral Nerve, Implanted (Pain Relief)
GZF is the FDA product code for stimulator, peripheral nerve, implanted (pain relief). It is a Class II device, regulated under 21 CFR 882.5870 and reviewed by the Neurology panel. FDA has cleared 25 510(k) submissions under GZF, 7 in the last five years, from 11 different applicants. The average 510(k) review took 184 days (median 175); 268 days on average over the last three years. FDA has posted 7 recalls for GZF devices, 1 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Stimulator, Peripheral Nerve, Implanted (Pain Relief) |
| Device class | Class II |
| Regulation | 21 CFR 882.5870 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
| Implant | Yes |
510(k) clearances per year for GZF
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 87 |
| 2019 | 3 | 164 |
| 2020 | 2 | 82 |
| 2021 | 1 | 339 |
| 2022 | 1 | 244 |
| 2023 | 1 | 341 |
| 2024 | 2 | 322 |
| 2025 | 2 | 218 |
| 2026 | 1 | 265 |
Compare with all 510(k) review times · Search every GZF clearance
Top GZF applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Medtronic Vascular | 8 | 2000-04-12 |
| Bioness, Inc. | 4 | 2022-02-23 |
| Bioventus, LLC | 3 | 2026-08-26 |
| Boston Scientific Neuromodulation | 2 | 2024-08-21 |
| Neuspera Medical, Inc. | 2 | 2023-04-11 |
6 more applicants have GZF clearances. See the full list in Caduvo.
Most recent GZF clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K253877 | Bioventus, LLC | StimTrial Neuromodulation System | 2026-08-26 | 265 |
| K243782 | Bioventus, LLC | StimTrial Neuromodulation System | 2025-07-16 | 219 |
| K243678 | Bioventus, LLC | TalisMann Neuromodulation System | 2025-07-03 | 218 |
| K232415 | Boston Scientific Neuromodulation | Nalu Neurostimulation System for Peripheral Nerve Stimulation | 2024-08-21 | 376 |
| K233162 | Curonix | Freedom Peripheral Nerve Stimulator (PNS) System | 2024-06-20 | 267 |
Recalls for GZF devices
7 product recalls in 2 recall events; 1 initiated in the last five years and 7 still open. Most recent: 2024-06-03.
| Year | Recalls |
|---|---|
| 2020 | 6 |
| 2024 | 1 |
Frequently asked questions
What is FDA product code GZF?
GZF is the FDA product code for stimulator, peripheral nerve, implanted (pain relief). It is a Class II device, regulated under 21 CFR 882.5870 and reviewed by the Neurology panel.
What device class is GZF?
Class II, regulation 21 CFR 882.5870. Typical premarket route: 510(k).
How long does a 510(k) take for product code GZF?
Across 25 cleared submissions the average was 184 days from receipt to decision (median 175).
Which companies have the most GZF clearances?
Medtronic Vascular (8); Bioness, Inc. (4); Bioventus, LLC (3); Boston Scientific Neuromodulation (2); Neuspera Medical, Inc. (2).
Have GZF devices been recalled?
Yes: 7 product recalls across 2 recall events; the most recent began 2024-06-03.
Next steps
- Run an FDA pathway report with predicate devices for product code GZF
- Run a recall and safety report across every GZF manufacturer
- Watch product code GZF for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times